alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
cme@

Chicago Mercantile Exchange

March 17, 2006

Ms. Jean A. Webb :
Office of the Secretariat >
Commodity Futures Trading Commission :
Three Lafayette Centre

1155 21° Street, NW Q
Washington, DC 20581 o

RE: Launch Date of Substitution of Futures for Forwards Facility, Suspension of
Eurodollar FRA Switches
Submitted per Sec. Se(c)(1) of the CEA and Regulation Sec. 40.6(a).
CME Submission # 06-23.

Dear Ms. Webb:

Chicago Mercantile Exchange (“CME” or “Exchange”) hereby certifies with the
Commission the effective date for the Substitution of Futures for Forwards rules. The Exchange
certifies that this amendment complies with the Act and rules thereunder.

On Monday, April 3, 2006, the Substitution of Futures for Forwards (SUBs) rules shall
be effective for the regular Eurodollar futures listed for trading and clearing, as well as Cleared-
Only Eurodollar futures. The deployment of the SUBs rules for currency futures shall be
deferred until an undetermined later date.

Further, the Exchange resolves to suspend, until further notice, the weekly matching of
daily expiring Eurodollar FRA pursuant to Rule 582. GLOBEX Switch Matching Algorithm. To
the extent that the specifications of the Eurodollar FRA contracts under Chapter 452B depart
from the Cleared-Only Eurodollar futures under Chapter 452, the suspension of the weekly
matching of the Chapter 452B contracts is intended to avoid any possible confusion. Currently,
there are no open interests in the affected Eurodollar FRA contracts.

20 South Wacker Drive, Chicago IL 60606-7499, Tel. 312-930-1000


Ms. Jean A. Webb
March 17, 2006
Page 2 of 6

Please do not hesitate to contact Mr. Richard Co at 312-930-3227 or rco@cme.com if any
questions arise during the processing of this submission. Please reference our CME Submission
#06-23 on all future correspondence for this submission.

Sincerely,

Zc
Hh be
LO FEF Y
a U”
John W. Labuszewski, Managing Director
Research & Product Development
Opinion issued September 2 7 , 2016

In The 

## Court of Appeals

For The 

## First District of Texas

———————————— NO. 01

- 16

- 00622

- CR

——————————— IN RE MIGUEL ANGEL Y EPEZ , Relator

Original Proceeding on Petition for Writ of Mandamus

MEMORANDUM OPINION
Miguel Angel Yepez has filed a petition for writ of mandamus challenging

the trial court’s June 20, 2016 order compelling him to submit to an HIV test under

Article 21.31 of the Texas Code of Criminal Procedure. 1

1 The underlying case is The State of Texas v. Miguel Angel Yepez , cause number 1412836, pending in the 174th District Court of Harris County, Texas, the Honorable Ruben Guerrero presiding.2

Because Yepez has not shown he is entitle d to relief, we deny the petition.

T EX

. R. A PP

. P. 52.8(a).

PER CURIAM

Panel consists of Chief Justice Radack and Justices Higley and Huddle. Do not publish. T EX

. R. A PP

. P. 47.2(b).
| 1.   | The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and |
|----------------|--------------------------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/ Michael Cordani                                                 |   |
|---------------------------------------------------------------------|--------|
| Michael CordaniChief Executive Officer(Principal Executive Officer) |   |

| 1.   | The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and |
|----------------|--------------------------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/ Michael Hull                                                 |   |
|------------------------------------------------------------------|--------|
| Michael HullChief Financial Officer(Principal Financial Officer) |   |
EX-10.14





 Exhibit 10.14 

Spousal Consent 
 The undersigned,
Junyi CHEN, (Identification Card No.: [            ]), is the lawful spouse of Qiuwen WANG (Identification Card No.:
[            ]). I hereby unconditionally and irrevocably agree to the execution of the following documents by Qiuwen WANG (hereinafter referred to collectively as the Transaction
Documents, for the avoidance of doubt, also including any other relevant documents as signed for conducting the transactions contemplated in the Transaction Documents, and as further amended, restated or supplemented from time to time), and the
disposal of the equity of Shanghai Caishuo Talent Information Consulting Co., Ltd. (the Company) registered in Qiuwen WANG’s name in accordance with the provisions of the following Transaction Documents: 

 

	 	1.	 The Exclusive Purchase Right Contract signed on September 30, 2016, by and among Qiuwen WANG, the Company
and CDP Information Technology (Shanghai) Co., Ltd (hereinafter referred to as Shanghai CDP);  


  

	 	2.	 The Equity Pledge Agreement signed on April 2, 2018, by and among Qiuwen WANG, Sufen LING, the Company and
Shanghai CDP; 


  

	 	3.	 The Power of Attorney signed and issued by Qiuwen WANG, on January 23, 2018. 



I hereby agree and confirm that I will not make any claim in respect of the equity held by Qiuwen WANG. I further confirm that, Qiuwen WANG can perform the
Transaction Documents and further amend or terminate the Transaction Documents or execute other agreements to replace the Transaction Documents without any separate authorization or consent from me. I undertake to execute all necessary documents and
take all necessary actions to ensure appropriate performance of the Transaction Documents. 
 I agree and undertake that, if for any reason I obtain any
equity held by Qiuwen WANG in the Company, I will be bound by the Transaction Documents and perform relevant obligations under the Transaction Documents as a shareholder of the Company. For such purpose, upon requested by Shanghai CDP, I will
execute such documents substantially equivalent with the Transaction Documents in terms of format and content. 
  

	
	Signature: /s/ Junyi
CHEN                                        

	
	Name: Junyi CHEN
	
	Date: September 9, 2019
EX-32.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report of ChineseWorldNet.com, Inc. (the "Company") on Form 20-F for the year ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Kelvin Fu Szeto, Chief Financial Officer and Chief Operating Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:





1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





Dated: April 29, 2011





/s/ Kelvin Fu Szeto


KELVIN FU SZETO


Chief Financial Officer and Chief Operating Officer
EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of SIMPLE TECH, Inc. (the "Company") on
Form 10-QSB for the period ending March 31, 2008, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Aviad Krief,
Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge and belief:

     (1)  the Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of the
          operation of the Company.


                                    /s/ Aviad Krief
                                    --------------------------------------------
                                    Aviad Krief
                                    Principal Financial Officer
                                    May 5, 2008

This certification accompanies this Report pursuant to ss.906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by Registrant for the purposes of
ss.18 of the Securities Exchange Act of 1934, as amended. This certification
shall not be incorporated by reference into any filing under the Securities Act
of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether
made before or after the date of this Report), irrespective of any general
incorporation language contained in such filing.

A signed original of this written statement required by ss.906 has been provided
to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
2006 Compensation Policy


 Exhibit 10.3 
  
 IMMUNICON CORPORATION 
  
 2006 COMPENSATION POLICY FOR NON-EMPLOYEE DIRECTORS 
  
 Effective January 1, 2006, the equity compensation of Immunicon’s non-employee directors is as follows: 
  

	 	•	 	Upon election to the Board, a new director will receive an option to purchase 25,000 shares of the common stock of Immunicon. 

  

	 	•	 	Each director will receive an annual option to purchase 15,000 shares of the common stock of Immunicon. 

  

	 	•	 	Each director who chairs a committee of the Board will receive an annual option to purchase 4,000 shares of the common stock of Immunicon. 

  
 Effective January 1, 2006, the cash compensation of
Immunicon’s non-employee directors is as follows: 
  

	 	•	 	$15,000 annual cash retainer for each director. 

  

	 	•	 	$10,000 annual cash retainer for the Audit and Compliance Committee chair. 

  

	 	•	 	$5,000 annual cash retainer for the Compensation Committee chair. 

  

	 	•	 	$5,000 annual cash retainer for the Nominating and Governance Committee chair. 

  

	 	•	 	$2,500 meeting fee for each director for each meeting of the Board attended in person. 

  

	 	•	 	$750 meeting fee for each director for each meeting of the Board attended via conference telephone. 

  

	 	•	 	$750 meeting fee for each committee member for each meeting of a committee of the Board attended in person. 

  

	 	•	 	$750 meeting fee for each committee member for each meeting of a committee of the Board attended via conference telephone. 

  
 Effective January 1, 2006, a non-executive chairperson of the Board will receive a
$50,000 annual cash retainer and an annual option to purchase 20,000 shares of the common stock of Immunicon vesting annually over two years (such chairperson will receive no other compensation for service on the Board or any of the committees of
the Board).
AMENDMENT

















AMENDMENT




TO THE




BORGWARNER INC. 2004
DEFERRED COMPENSATION PLAN




Authorization of
Special Elections for Code Section 409A




            Pursuant to guidance issued by the Internal
Revenue Service under notices and proposed regulations for Section 409A of the
Internal Revenue Code, the BorgWarner Inc. 2004 Deferred Compensation Plan
("Plan") is hereby amended, effective as of January 1, 2005, as follows:  




	2005 Special Elections.  The Plan is amended to authorize
     the special elections offered by the Corporation to participants in the
     Plan to amend or rescind, on or before March 15, 2005, their previous
     deferral elections with respect to (1) bonuses payable in 2005, and (2)
     2005 salary deferrals ("2005 Special Elections"); and, in the case of
     rescissions, to distribute the deferred amounts to participants on or
     before December 31, 2005.

       
	Any and all provisions of the Plan which conflict with the
     2005 Special Elections authorization of Paragraph 1 of this Amendment, are
     hereby deemed amended and shall be interpreted to give effect to the
     Special Elections authorization.

     

 
	Until such time as the Plan is amended in its entirety for
     Code Section 409A following the issuance of final Internal Revenue Code
     regulations for Code Section 409A or such earlier time as may be required
     by the Internal Revenue Service, the Plan shall be administered in
     accordance with the requirements of Code section 409A for deferred amounts
     that are subject to Code Section 409A.
<PAGE>

                                                                   EXHIBIT 10.14

                    Dr. Archie Dykes
                    Chairman of Compensation Committee
                    Board of Directors

November 11, 2002

Mr. Robert R. Schoeberl

Dear Mr. Schoeberl:

Bob, this letter confirms the Board's agreement with you regarding position,
compensation and expense reimbursement.

Position:         Non-Executive Chairman of the Board

Supplemental
Directors Fee:    $150,000 -- Paid in quarterly installments for one year
                  (effective October 1, 2002)  -- inclusive of fees otherwise
                  payable under the company's by-laws. As needed assistance
                  except as specified in the company's by-laws.

Non-Qualified     15,000 Restricted Shares and 35,000 Options (Vesting ratably
Options:          over three years on each anniversary) -- Options priced as of
                  close of business on November 11, 2002.

Expenses:         Reimbursement for reasonable travel and business related
                  expenses.


                           Sincerely,

                           /s/ Dr. Archie Dykes
                           ---------------------------
                           Dr. Archie Dykes
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2035 Received in Senate (RDS)]

<DOC>
116th CONGRESS
  1st Session
                                H. R. 2035

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 25, 2019

                                Received

_______________________________________________________________________

                                 AN ACT

 
To amend title XXIX of the Public Health Service Act to reauthorize the 
      program under such title relating to lifespan respite care.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Lifespan Respite Care 
Reauthorization Act of 2019''.

SEC. 2. REAUTHORIZATION OF LIFESPAN RESPITE CARE PROGRAM.

    (a) Data Collection and Reporting.--Section 2904 of the Public 
Health Service Act (42 U.S.C. 290ii-3) is amended to read as follows:

``SEC. 2904. DATA COLLECTION AND REPORTING.

    ``Each eligible State agency awarded a grant or cooperative 
agreement under section 2902 shall collect, maintain, and report such 
data and records at such times, in such form, and in such manner as the 
Secretary may require to enable the Secretary--
            ``(1) to monitor State administration of programs and 
        activities funded pursuant to such grant or cooperative 
        agreement; and
            ``(2) to evaluate, and to compare effectiveness on a State-
        by-State basis, of programs and activities funded pursuant to 
        section 2902.''.
    (b) Funding.--Section 2905 of the Public Health Service Act (42 
U.S.C. 300ii-4) is amended by striking paragraphs (1) through (5) and 
inserting the following:
            ``(1) $20,000,000 for fiscal year 2020;
            ``(2) $30,000,000 for fiscal year 2021;
            ``(3) $40,000,000 for fiscal year 2022;
            ``(4) $50,000,000 for fiscal year 2023; and
            ``(5) $60,000,000 for fiscal year 2024.''.

            Passed the House of Representatives July 24, 2019.

            Attest:

                                             CHERYL L. JOHNSON,

                                                                 Clerk.
```
#### The People of the State of New York, Respondent, v Carol Young, Appellant.

Appeal by the defendant from a judgment of the Supreme Court, Kings County (Lombardo, J.), rendered May 9, 1986, convicting her of manslaughter in the first degree, upon her plea of guilty, and imposing sentence.

Ordered that the judgment is modified, as a matter of discretion in the interest of justice, by reducing the sentence from *8V3*to 25 years’ imprisonment, to 5 to 15 years’ imprisonment; as modified, the judgment is affirmed.

The defendant’s claim that her plea of guilty should be vacated is not preserved for appellate review as a question of law *(see, People v Lopez,*71 NY2d 662; *People v Claudio,*64 NY2d 858; *People v Pellegrino,*60 NY2d 636), and review of this question in the interest of justice is not warranted. However, we find that the sentence imposed was excessive to the extent indicated. Bracken, J. P., Kunzeman, Sullivan and Balletta, JJ., concur.
I 

116TH CONGRESS 

1ST SESSION H. R. 1823 

To provide opioid receptor antagonists, including naloxone, to first responders 

for personal use, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 18, 2019 

Mr. GIBBS (for himself, Mr. MEADOWS, Mr. GOSAR, Mr. DAVID P. ROE of 

Tennessee, Mr. LUETKEMEYER, Mr. DIAZ-BALART, Mr. HICE of Georgia, 

Mr. GUEST, Mr. BUDD, Mr. WRIGHT, and Mr. GROTHMAN) introduced 

the following bill; which was referred to the Committee on the Judiciary, 

and in addition to the Committee on Science, Space, and Technology, for 

a period to be subsequently determined by the Speaker, in each case for 

consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To provide opioid receptor antagonists, including naloxone, 

to first responders for personal use, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Help Ensure Respond5 ers Overdosing Emerge Safely Act of 2019’’ or the ‘‘HE6 ROES Act of 2019’’. 


kjohnson on DSK79L0C42 with BILLS
2 

•HR 1823 IH

1 SEC. 2. ASSISTANCE TO FIREFIGHTERS GRANTS PROGRAM 

2 AND THE FIRE PREVENTION AND SAFETY 

3 GRANTS PROGRAM. 

4 (a) FIRE PREVENTION AND SAFETY GRANTS PRO5 GRAM.—Section 33(c)(3) of the Federal Fire Prevention 

6 and Control Act of 1974 (15 U.S.C. 2229(c)(3)) is amend7 ed by adding at the end the following: 

8 ‘‘(O) To provide opioid receptor antago9 nists, including naloxone, to firefighters, para10 medics, emergency medical service workers, and 

11 other first responders for personal use.’’. 

12 (b) COPS GRANT.—Section 1701(b) of the Omnibus 

13 Crime Control and Safe Streets Act of 1968 (34 U.S.C. 

14 10381(b)(13)) is amended— 

15 (1) in paragraph (22), by striking ‘‘and’’ at the 

16 end; 

17 (2) in paragraph (23), by striking the period 

18 and inserting ‘‘; and’’; and 

19 (3) by adding at the end the following: 

20 ‘‘(24) to provide opioid receptor antagonists, in21 cluding naloxone, to law enforcement officers for 

22 personal use.’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
Case 1:07-cv-05563-AKH Document 3 Filed 08/03/2007 Page 1 of 5
Case 1:07-cv-05563-AKH Document 3 Filed 08/03/2007 Page 2 of 5
Case 1:07-cv-05563-AKH Document 3 Filed 08/03/2007 Page 3 of 5
Case 1:07-cv-05563-AKH Document 3 Filed 08/03/2007 Page 4 of 5
Case 1:07-cv-05563-AKH Document 3 Filed 08/03/2007 Page 5 of 5
I 

116TH CONGRESS 

1ST SESSION H. R. 1904 

To amend the Omnibus Public Land Management Act of 2009 to make 

the Reclamation Water Settlements Fund permanent. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 27, 2019 

Mr. GRIJALVA (for himself, Mr. GALLEGO, Ms. HAALAND, Ms. GABBARD, and 

Mr. O’HALLERAN) introduced the following bill; which was referred to the 

Committee on Natural Resources 

A BILL 

To amend the Omnibus Public Land Management Act of 

2009 to make the Reclamation Water Settlements Fund 

permanent. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Indian Water Rights 

5 Settlement Extension Act’’. 

6 SEC. 2. RECLAMATION WATER SETTLEMENTS FUND. 

7 Section 10501 of the Omnibus Public Land Manage8 ment Act of 2009 (43 U.S.C. 407) is amended— 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•HR 1904 IH

1 (1) in subsection (b)(1), by striking ‘‘For each 

2 of fiscal years 2020 through 2029’’ and inserting 

3 ‘‘For fiscal year 2020 and each fiscal year there4 after’’; 

5 (2) in subsection (c)— 

6 (A) in paragraph (1)(A), by striking ‘‘for 

7 each of fiscal years 2020 through 2034’’ and 

8 inserting ‘‘for fiscal year 2020 and each fiscal 

9 year thereafter’’; and 

10 (B) in paragraph (3)(C), by striking ‘‘for 

11 any authorized use’’ and all that follows 

12 through the period at the end and inserting 

13 ‘‘for any use authorized under paragraph (2).’’; 

14 and 

15 (3) by striking subsection (f). 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS